Matinas BioPharma MTNB Q3 2025 earnings
Reported November 10, 2025 · Before market open
EPS-$0.40
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$25.0K
EPS estimate-$1.50
Versus estimates
Ask the moment Matinas BioPharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Matinas BioPharma report Q3 2025 earnings?
- Matinas BioPharma (MTNB) reported Q3 2025 earnings on November 10, 2025 before market open.
- What were Matinas BioPharma's Q3 2025 revenue and EPS?
- Matinas BioPharma reported eps of $-0.40 for Q3 2025.
- How did Matinas BioPharma's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 52.9% from $-0.85.
- Where can I find Matinas BioPharma's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001493152-25-021506) directly on SEC EDGAR. The filing index links above go to sec.gov.